US Capital Global Securities Launches $50MM Equity Offering in Zenion Laboratories

Explore an exclusive investment opportunity in Zenion Laboratories: a water security pioneer using carbon nanotechnology to provide high-volume, low-cost, chemical-free drinking water.

SAN FRANCISCO, JULY 2024 – US Capital Global Securities LLC, an SEC-registered affiliate of renowned global financial group US Capital Global, is pleased to present eligible investors with a unique investment opportunity to participate in an investment round of up to $50 million for Zenon Laboratories (“Zenion” or the “Company”). Initially funded by NASA and deployed on the International Space Station, Zenion’s nanotechnology products provide low-cost, chemical-free drinking water that is inordinately superior to existing purification, filtration, and flocculation solutions.

Based in Delaware, Zenion offers a suite of connected products designed for the purification of water, water quality detection, and water health analytics. Leveraging advanced nanotechnology and photochemistry, the Company’s solutions break down and eliminate pharmaceuticals, toxic chemicals, nano-scale microplastics, and all viral and bacterial contaminants that threaten global water sources. Zenion’s revenue streams derive from unit sales, maintenance contracts, royalties from purified water sales, and water quality data services.

“Current water-purification technologies fall short in fully eliminating harmful contaminants,” stated Zenion Founder and CEO, Chris Cooper, who has devoted 24 years to developing advanced water-purification technology. “Zenion offers an endless supply of clean, pure water with a closed-loop system that removes pathogens and chemical contaminants, ensuring perpetual water security. Utilizing carbon nanotechnology, we are poised to revolutionize the water-purification industry and lead the charge in delivering chemical-free drinking water. We welcome you to join us at the forefront of this industrial revolution.”

“Zenion’s mission is to revolutionize water security across the globe with its breakthrough nanotechnology,” added Charles Towle, CEO at US Capital Global Securities LLC. “The Company has already entered the emergency and remote mobile water-purification markets to deliver clean, life-saving water to populations affected by disasters. We believe that Zenion presents a compelling opportunity for investors with its distinctive $50 million equity offering currently available to eligible participants.”

About Zenion Laboratories

Zenion Laboratories pioneers global water security with breakthrough nanotechnology. Specializing in revolutionary purification technology, Zenion enhances natural water sources and closed-loop systems, significantly lowering purified water costs while eliminating pharmaceuticals, toxins, microplastics, and contaminants to a degree unparalleled by any known competitors. The Company offers a range of connected products for water purification, water quality detection, and water health intelligence that support global municipal water supplies and emergency response markets. To learn more, visit www.zenionlaboratories.com.

About US Capital Global

US Capital Global Securities LLC (“USCGS”) serves as the FINRA-member broker-dealer division of US Capital Global, specializing in facilitating growth-stage investments. Since 1998, US Capital Global has been dedicated to providing lower middle market businesses and investors with sophisticated investment opportunities. For further details about US Capital Global Securities or this investment opportunity, contact Frank Villarreal, Managing Director and Partner, at fvillarreal@uscapital.com or call +1 415-350-4092.

Disclaimer: USCGS or its affiliates may provide advice to, be compensated by, have other business relationships with, or may from time to time acquire, hold, or sell a position in the securities of the issuers mentioned herein. Any offer or solicitation shall be made only pursuant to the confidential private placement memorandum. View USCGS’ Form CRS at www.uscapglobalsecurities.com/crs.html.